These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5336629)

  • 1. An evaluation of CI-564 against blood-induced chlorguanide-sensitive and chlorguanide-resistant strains of vivax malaria.
    Chin W; Coatney GR; King HK
    Am J Trop Med Hyg; 1967 Jan; 16(1):13-4. PubMed ID: 5336629
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of cycloguanil pamoate (CI-501) against a chlorguanide-resistant Chesson strain of Plasmodium vivax.
    Chin W; Lunn JS; Buxbaum J; Contacos PG
    Am J Trop Med Hyg; 1965 Nov; 14(6):922-4. PubMed ID: 5320455
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy of the drug-resistant malarias.
    Schmidt LH
    Annu Rev Microbiol; 1969; 23():427-54. PubMed ID: 4901983
    [No Abstract]   [Full Text] [Related]  

  • 4. The problem of drug-resistant malaria.
    Clyde DF
    Am J Trop Med Hyg; 1972 Sep; 21(5):736-43. PubMed ID: 4561521
    [No Abstract]   [Full Text] [Related]  

  • 5. Polyresistant malaria in Gurkha soldiers returning from Papua New Guinea: treatment and prevention.
    Henderson A; Simon J; Melia W; Navein J; McCallum J
    J R Army Med Corps; 1986 Feb; 132(1):37-41. PubMed ID: 3517314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the chemotherapy of malaria.
    Pinder RM
    Prog Med Chem; 1971; 8(2):231-316. PubMed ID: 4947769
    [No Abstract]   [Full Text] [Related]  

  • 7. Development of new antimalarial drugs.
    Powell RD
    Am J Trop Med Hyg; 1972 Sep; 21(5):744-8. PubMed ID: 4561522
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drug resistance of Plasmodium falciparum and Plasmodium vivax strains in Cambodia (Cardamone Massif). Morphological characteristics of Plasmodium vivax].
    Lapierre J; Coquelin B; Galal AA; Dupouy-Camet J; Faurant C; Tourte-Schaefer C; Ancelle T; Heyer F
    Med Trop (Mars); 1984; 44(4):339-49. PubMed ID: 6394948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of malaria.
    Rozman RS
    Annu Rev Pharmacol; 1973; 13():127-52. PubMed ID: 4576886
    [No Abstract]   [Full Text] [Related]  

  • 10. Some pharmacological aspects of antimalarial drugs.
    Botha D
    S Afr Med J; 1974 Jun; 48(29):1263-5. PubMed ID: 4607434
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy of malaria.
    Talukdar B
    Indian Pediatr; 1986 May; 23(5):371-5. PubMed ID: 3527970
    [No Abstract]   [Full Text] [Related]  

  • 12. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE EFFECT OF A REPOSITORY PREPARATION OF THE DIHYDROTRIAZINE METABOLITE OF CHLORGUANIDE, CI-501, AGAINST THE CHESSON STRAIN OF PLASMODIUM VIVAX IN MAN.
    COATNEY GR; CONTACOS PG; LUNN JS; KILPATRICK JW; ELDER HA
    Am J Trop Med Hyg; 1963 Jul; 12():504-8. PubMed ID: 14044760
    [No Abstract]   [Full Text] [Related]  

  • 14. Activities of respository preparations of cycloguanil pamoate and 4,4'-diacetyldiaminodiphenylsulfone, alone and in combination, against infections with Plasmodium cynomolgi in rhesus monkeys.
    Schmidt LH; Rossan RN
    Antimicrob Agents Chemother; 1984 Nov; 26(5):611-42. PubMed ID: 6393864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of drugs in a malaria program.
    Bruce-Chwatt LJ
    Am J Trop Med Hyg; 1972 Sep; 21(5):731-5. PubMed ID: 5074690
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tolerance of Plasmodium falciparum to pyrimethamine, proguanil and C.I. 501 in the Niayes region (Senegal)].
    Michel R; Pene P; Courtney KO
    Bull Soc Pathol Exot Filiales; 1966; 59(5):797-803. PubMed ID: 6014281
    [No Abstract]   [Full Text] [Related]  

  • 17. The urinary excretion and the antimalarial activity of CI-501 (cycloguanil-pamoate, Camolar) against vivax and falciparum malaria.
    Contacos PG; Coatney GR; Lunn JS; Chin W
    Am J Trop Med Hyg; 1966 May; 15(3):281-6. PubMed ID: 5328125
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of CI-564, A 1:1 mixture of cycloguanil pamoate (CI-501) and 4,4'-diacetylaminodiphenylsulfone (CI-556), against multiresistant falciparum malarias.
    Chin W; Contacos PG; Coatney GR; Jeter MH; Alpert E
    Am J Trop Med Hyg; 1967 Sep; 16(5):580-4. PubMed ID: 4861322
    [No Abstract]   [Full Text] [Related]  

  • 19. [Plasmodium resistance to antimalarials].
    Cailhol J; Consigny PH
    Rev Prat; 2014 Dec; 64(10):1433-4. PubMed ID: 25665330
    [No Abstract]   [Full Text] [Related]  

  • 20. [The proper use of antimalarial drugs currently available].
    Bourgeade A; Delmont J
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.